Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norma Bloy

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of the National Cancer Institute|December 11, 2024
Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor-positive mammary carcinogenesisAitziber Buqué, Norma Bloy, Giulia Petroni, et al.
Immunological Reviews|October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillanceNorma Bloy, Pauline Garcia, Céline M Laumont, et al.
Cell Death Discovery|December 10, 2020
Autophagy-mediated metabolic effects of aspirinFrancesca Castoldi, Juliette Humeau, Isabelle Martins, et al.
Journal for Immunotherapy of Cancer|June 24, 2021
Metabolic features of cancer cells impact immunosurveillanceAdrien Joseph, Pan Juncheng, Michele Mondini, et al.
Nature Communications|August 1, 2020
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Communications|September 18, 2020
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Cancer Cell|July 15, 2016
Caloric Restriction Mimetics Enhance Anticancer ImmunosurveillanceFederico Pietrocola, Jonathan Pol, Erika Vacchelli, et al.
The Journal of Experimental Medicine|September 8, 2021
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinomaJuliette Paillet, Céleste Plantureux, Sarah Lévesque, et al.
Nature Cancer|July 7, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophagesGiulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Nature Cancer|July 23, 2025
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophagesGiulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of the National Cancer Institute|December 11, 2024
Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor-positive mammary carcinogenesisAitziber Buqué, Norma Bloy, Giulia Petroni, et al.
Immunological Reviews|October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillanceNorma Bloy, Pauline Garcia, Céline M Laumont, et al.
Cell Death Discovery|December 10, 2020
Autophagy-mediated metabolic effects of aspirinFrancesca Castoldi, Juliette Humeau, Isabelle Martins, et al.
Journal for Immunotherapy of Cancer|June 24, 2021
Metabolic features of cancer cells impact immunosurveillanceAdrien Joseph, Pan Juncheng, Michele Mondini, et al.
Nature Communications|August 1, 2020
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Communications|September 18, 2020
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Cancer Cell|July 15, 2016
Caloric Restriction Mimetics Enhance Anticancer ImmunosurveillanceFederico Pietrocola, Jonathan Pol, Erika Vacchelli, et al.
The Journal of Experimental Medicine|September 8, 2021
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinomaJuliette Paillet, Céleste Plantureux, Sarah Lévesque, et al.
Nature Cancer|July 7, 2025
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophagesGiulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Nature Cancer|July 23, 2025
Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR<sup>+</sup>HER2<sup>-</sup> breast cancer via CX3CR1<sup>+</sup> macrophagesGiulia Petroni, Claudia Galassi, Kenneth H Gouin, et al.
Pageof 6